Your browser doesn't support javascript.
loading
Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies.
Tada, Takuya; Zhou, Hao; Samanovic, Marie I; Dcosta, Belinda M; Cornelius, Amber; Herati, Ramin S; Mulligan, Mark J; Landau, Nathaniel R.
Afiliación
  • Tada T; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, United States.
  • Zhou H; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, United States.
  • Samanovic MI; Department of Medicine, NYU Grossman School of Medicine, New York, NY, United States.
  • Dcosta BM; NYU Langone Vaccine Center, NYU Grossman School of Medicine, New York, NY, United States.
  • Cornelius A; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, United States.
  • Herati RS; Department of Medicine, NYU Grossman School of Medicine, New York, NY, United States.
  • Mulligan MJ; NYU Langone Vaccine Center, NYU Grossman School of Medicine, New York, NY, United States.
  • Landau NR; Department of Medicine, NYU Grossman School of Medicine, New York, NY, United States.
Front Immunol ; 13: 797589, 2022.
Article en En | MEDLINE | ID: mdl-35350781
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos